Form D · Pharmaceuticals

Novosteo Inc.

West Lafayette, IN · CIK 0001840600

Offering snapshot reported Apr 21, 2022 · SEC filing

Reported sold
$17.7M
Offering amount: $17.7M
Investors reported
37
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 29, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$8.84M$17.7MJan 14, 2021: $4,289,758.00Jan 14, 2021Nov 10, 2021: $5,689,758.00Nov 10, 2021Nov 22, 2021: $8,387,043.00Apr 21, 2022: $17,687,040.00Apr 21, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$8,387,043 → $17,687,040
  • Reported investors21 → 37

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2022Amendment$17,687,040$9,299,997vs Nov 22, 202137SEC filing
Nov 22, 2021Amendment$8,387,043$2,697,285vs Nov 10, 202121SEC filing
Nov 10, 2021Amendment$5,689,758$1,400,000vs Jan 14, 20218SEC filing
Jan 14, 2021Initial$4,289,758No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-386400
Includes amounts paid in both cash and pursuant to conversion of indebtedness.

Source: Form D, filed Apr 21, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alex Andrianopoulos Director
William J. Boyle, Ph.D. Director, Executive
Martin Brena, Ph.D. Director
Daniel Hasler Director
Dan Hasler Director
Pascal Krotee Director
David Lamond Director
Stewart A. Low, Ph.D. Executive
Philip S. Low, Ph.D. Director, Executive
William J. Rutter Director
Dirk Thye, M.D. Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1281 Win Hentschel Blvd.
West Lafayette, IN, 47906